MoveFitRx Aims to Make Exercise a Verifiable Medical Prescription

SAN DIEGO, March 13, 2026 – Health technology firm MoveFitRx today announced the launch of its Clinical Intelligence Layer, a new platform designed to fundamentally change how the healthcare system treats physical activity. The company aims to elevate exercise from a general recommendation to a structured, verifiable, and reimbursable medical intervention, effectively building the infrastructure to establish movement as a formal standard of care.

For decades, the mantra "exercise is medicine" has been championed by medical bodies worldwide, yet it has largely remained disconnected from formal clinical practice due to a lack of objective tracking and verification. MoveFitRx seeks to solve this systemic problem with a HIPAA-compliant portal that allows physicians to prescribe diagnosis-specific exercise regimens and digitally confirm patient adherence.

"Healthcare has incredible tools for prescribing medication, but has lacked the infrastructure to prescribe, track, and validate movement," said Garrett Borunda, Founder and CEO of MoveFitRx, in a statement. "By providing doctors with validated evidence of adherence, we are enabling the healthcare system to treat exercise with the same clinical rigor as a pharmaceutical intervention."

The Clinical Case for Prescribed Movement

The concept behind MoveFitRx is not new; it is the culmination of decades of research and advocacy. Global health organizations like the World Health Organization (WHO) and professional bodies such as the American College of Sports Medicine (ACSM) have long established the critical role of physical activity in preventing and managing chronic disease. The ACSM's own 'Exercise is Medicine' initiative, founded in 2007, has worked to make physical activity assessment a standard part of clinical care.

Medical consensus is clear: physical activity is a powerful, yet underutilized, treatment. Studies show that structured exercise can improve outcomes for a vast range of conditions, from metabolic and cardiovascular disease to mental health and cancer recovery. For example, recent guidelines for cancer survivors emphasize exercise to manage fatigue, anxiety, and even improve survival rates. Despite this evidence, the inability for clinicians to easily prescribe, monitor, and be reimbursed for specific exercise protocols has been a significant barrier to widespread adoption.

MoveFitRx is entering the market to provide the missing link: a technological bridge between clinical intent and patient action. By creating a standardized system for prescription and verification, the platform aims to empower clinicians to use exercise as a targeted therapeutic tool, rather than a generic piece of advice.

Bridging the Gap with Technology and Data

At the heart of the MoveFitRx platform is its patent-pending "Logic Engine," developed by Borunda, a Stanford graduate and Apple alum with executive experience at fitness giants like EGYM and 24 Hour Fitness. This engine powers the platform's "Clinical Intelligence Layer," which translates a physician's clinical diagnosis into a structured, evidence-based exercise prescription tailored to the patient's specific condition and needs.

The process begins in the clinician's office. Through a secure portal, a doctor can input a patient's diagnosis—focusing initially on high-impact areas like Metabolic Health, Mental Wellness, and Women's Health. The Logic Engine then generates a precise exercise plan. The patient receives this plan through a connected application, which guides them through the activities and captures adherence data. This data is then securely transmitted back to the clinician's dashboard, providing objective proof of engagement.

This closed-loop system is designed to be fully HIPAA-compliant, ensuring patient data is protected. Borunda's background, which includes a patent for ultra-low delay reference decoders, points to a deep understanding of complex data systems, suggesting the platform is built for robust and responsive data handling.

The Financial Framework: RTM and the Business of Wellness

Perhaps the most critical component for market adoption is how MoveFitRx aligns with new healthcare reimbursement models. The platform is explicitly designed to support Remote Therapeutic Monitoring (RTM) workflows. Introduced by the Centers for Medicare & Medicaid Services (CMS) in 2022, RTM codes allow healthcare providers to bill for the remote monitoring of patients' therapeutic and treatment responses, including adherence to a prescribed regimen.

This is a game-changer for exercise prescription. RTM codes, such as those covering musculoskeletal system status and therapy adherence (e.g., CPT codes 98977, 98980, 98981), provide a direct financial incentive for clinicians to adopt platforms that can track non-physiological data. By providing digitally verified adherence data for at least 16 days a month—a key RTM requirement—MoveFitRx gives providers the objective documentation needed to bill for their time spent managing a patient's exercise therapy.

This transforms exercise from an uncompensated recommendation into a billable clinical service. It creates a viable business case for providers to invest time and resources into managing patient activity levels, potentially leading to better patient outcomes and a reduction in long-term healthcare costs associated with chronic disease.

Navigating a Crowded Digital Health Landscape

MoveFitRx enters a competitive digital health market populated by wellness apps, digital therapeutics (DTx) companies, and remote monitoring platforms. Companies like Omada Health and Hinge Health already offer robust digital programs for chronic and musculoskeletal conditions, respectively, often including exercise components and coaching. Meanwhile, consumer tech giants like Apple and Google (via Fitbit) have made significant inroads into health and activity tracking.

However, MoveFitRx is positioning itself not as another fitness app, but as an essential intelligence layer that integrates with the healthcare system. Its key differentiator is the direct translation of a formal medical diagnosis into a verifiable prescription, creating a clear audit trail for clinical and billing purposes. Unlike general wellness platforms, it is not meant for the self-motivated consumer but for the patient who requires a specific therapeutic intervention. By connecting clinicians, patients, and even physical fitness facilities, it aims to create a new, integrated ecosystem for medical exercise.

From Pilot to Practice: The Road Ahead

With the platform's launch, MoveFitRx is now activating its Spring 2026 roadmap. A crucial next step is a 50-patient live clinical pilot in San Diego, designed to verify the platform's end-to-end "clinical-to-machine data flow." This initial trial will focus on ensuring the technology works seamlessly—from the doctor's prescription to the patient's activity and back to the clinical dashboard.

While the pilot will provide essential technical validation, the broader challenges of market adoption lie ahead. Success will depend on seamless integration with existing Electronic Health Record (EHR) systems to avoid disrupting clinical workflows, as well as convincing time-constrained physicians of the platform's value and ease of use. Furthermore, maintaining long-term patient engagement and adherence will remain a central challenge, as it is for all health interventions.

Despite these hurdles, the opportunity is immense. With the rising tide of chronic disease and a systemic shift towards value-based, preventive care, the demand for scalable and effective lifestyle interventions has never been greater. By providing the missing infrastructure to make exercise a core component of medical treatment, MoveFitRx is poised to play a significant role in shaping the future of clinical care.